Lexicon Pharmaceuticals Inc (LXRX)
1.60
+0.06
(+3.90%)
USD |
NASDAQ |
Apr 26, 09:59
Lexicon Pharmaceuticals Debt to Equity Ratio: 1.069 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.069 |
| September 30, 2023 | 0.7115 |
| June 30, 2023 | 0.53 |
| March 31, 2023 | 0.5548 |
| December 31, 2022 | 0.4148 |
| September 30, 2022 | 0.1651 |
| June 30, 2022 | 0.3336 |
| March 31, 2022 | 0.2533 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0856 |
| June 30, 2021 | 0.0851 |
| March 31, 2021 | 0.0764 |
| December 31, 2020 | 0.0745 |
| September 30, 2020 | 0.2319 |
| June 30, 2020 | -22.95 |
| March 31, 2020 | 4.477 |
| December 31, 2019 | 2.094 |
| September 30, 2019 | 1.488 |
| June 30, 2019 | -3.777 |
| March 31, 2019 | -5.363 |
| December 31, 2018 | -9.279 |
| September 30, 2018 | -8.331 |
| June 30, 2018 | -48.33 |
| March 31, 2018 | 9.368 |
| December 31, 2017 | 3.599 |
| Date | Value |
|---|---|
| September 30, 2017 | 1.278 |
| June 30, 2017 | 0.9457 |
| March 31, 2017 | 0.7505 |
| December 31, 2016 | 0.6445 |
| September 30, 2016 | 0.5499 |
| June 30, 2016 | 0.4702 |
| March 31, 2016 | 0.4056 |
| December 31, 2015 | 0.3601 |
| September 30, 2015 | 0.537 |
| June 30, 2015 | 0.4612 |
| March 31, 2015 | 0.4162 |
| December 31, 2014 | 0.3791 |
| September 30, 2014 | 0.2648 |
| June 30, 2014 | 0.1803 |
| March 31, 2014 | 0.1524 |
| December 31, 2013 | 0.1286 |
| September 30, 2013 | 0.12 |
| June 30, 2013 | 0.1054 |
| March 31, 2013 | 0.0952 |
| December 31, 2012 | 0.0879 |
| September 30, 2012 | 0.0943 |
| June 30, 2012 | 0.0988 |
| March 31, 2012 | 0.0912 |
| December 31, 2011 | 0.0837 |
| September 30, 2011 | 0.1489 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-22.95
Minimum
Jun 2020
4.477
Maximum
Mar 2020
-0.7412
Average
0.2533
Median
Mar 2022
Debt to Equity Ratio Benchmarks
| Novavax Inc | -0.2344 |
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 229.43M |
| Total Liabilities (Quarterly) | 136.32M |
| Shareholders Equity (Quarterly) | 93.11M |
| Current Ratio | 5.596 |
| Net Debt Paydown Yield | -4.04% |